Below is a listing of treatments, therapies, and surgeries for COPD. Click on one to read more information or connect with others currently using it.
Overview
AirDuo RespiClick is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma in people age 12 years and older. AirDuo RespiClick may be prescribed off-label in cases of chronic… read more
Overview
Alvesco is a prescription drug approved by the Food and Drug Administration (FDA) in 2008 for maintenance treatment of asthma in people 12 years of age and older. In chronic obstructive pulmonary disease… read more
Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more
Overview
Aralast NP is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more
Overview
Arcapta is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 for maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD). Arcapta is not… read more
Overview
Arnuity Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Arnuity Ellipta is not… read more
Overview
Atrovent is a prescription drug approved by the Food and Drug Administration (FDA) for the maintenance treatment of bronchospasms caused by asthma, allergies, chronic obstructive pulmonary disease (COPD), and… read more
Overview
Bevespi Aerosphere is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more
Overview
Breo Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2013 for daily maintenance treatment in cases of chronic obstructive pulmonary disease (COPD). Breo Ellipta helps… read more
Overview
Breztri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as long-term, daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more
Overview
Brovana is a prescription drug first approved by the Food and Drug Administration (FDA) for long-term maintenance of bronchoconstriction in chronic obstructive pulmonary disease (COPD). Brovana is not… read more
Overview
In people with chronic obstructive pulmonary disease (COPD), the structure of the lung weakens. The alveoli, tiny sacs of air where carbon dioxide is exchanged for oxygen, may become damaged. If the alveoli… read more
Overview
Combivent Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Combivent Respimat is… read more
Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a… read more
Overview
Duaklir Pressair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more
Overview
DuoNeb is a prescription drug approved by the Food and Drug Administration (FDA) to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD) who need more than one bronchodilator. DuoNeb… read more
Overview
Dupixent is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (high levels…
Overview
Elixophyllin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and…
Overview
Fasenra is a prescription medication approved by the Food and Drug Administration (FDA) to treat severe asthma in people age 12 and older. Fasenra may be prescribed in cases of asthma that test positive for an… read more
The Foradil brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
Overview
Glassia is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin deficiency, a rare genetic… read more
Overview
Incruse Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary… read more
Overview
Lonhala Magnair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD).… read more
Overview
Lung transplant may be an option for some people with end-stage chronic obstructive pulmonary disease (COPD) who have tried every other avenue of treatment. Lung transplants may involve one (single-lung… read more
Overview
Lung volume reduction surgery is an option for some people with severe, advanced emphysema, a type of chronic obstructive pulmonary disease (COPD). In these people, the lungs are hyperinflated and cannot… read more
Become a member to get even more